Pentagon: Iran has launched more than 2,000 drones in Middle East so far
The U.S. military's Central Command said on Tuesday that Iran has launched over 500 ballistic missiles and ...
Scientists have developed an AI tool called FaceAge that analyzes selfies to estimate biological age, predict cancer survival rates, and assist in healthcare decisions. The tool has demonstrated remarkable accuracy, outperforming clinicians in some cases, and could revolutionize health diagnostics.
Published in The Lancet Digital Health, the study involved training the AI on nearly 59,000 facial images to estimate biological age—an indicator of cellular health distinct from chronological age.
FaceAge was tested on 6,200 cancer patients, revealing that on average, they appeared biologically five years older than their chronological age. This data suggested a link between accelerated aging and cancer. Notably, the AI was also tested on 100 palliative care patients to predict life expectancy. Its predictions were more accurate than those of 10 experienced clinicians.
Dr. Ray Mak, one of the study’s authors, emphasized the tool’s potential as an early detection system for health issues, particularly as aging-related diseases become more prevalent.
However, the tool’s accuracy may vary due to factors like limited training diversity and external influences such as makeup and lighting. Researchers are working to refine the model by expanding datasets and conducting further testing.
Though its clinical implementation may be years away, FaceAge is opening new avenues in health diagnostics and biomarker discovery, promising advancements in early detection and personalized care.
The Kremlin is utilising the recent United States and Israeli military strikes on Iran to validate its ongoing war in Ukraine. Russian officials are pointing to the escalation in the Middle East as evidence that Western nations do not adhere to international rules.
Saudi Arabia’s state oil giant Saudi Aramco closed its Ras Tanura refinery on Monday following an Iranian drone strike, an industry source told Reuters as Tehran retaliated across the Gulf after a U.S.-Israeli attack on Iranian targets over the weekend.
U.S. President Donald Trump said the U.S. military has enough stockpiled weapons to fight wars "forever"; in a social media post late on Monday. The remarks came hours before conflict in Iran and the Middle East entered its fourth day.
Türkiye raised its security level for Turkish-flagged vessels in the Strait of Hormuz to Level 3 on Sunday (2 March). The development follows Iranian restrictions on shipping after U.S. and Israeli strikes and confirmation of Supreme Leader Ali Khamenei’s death.
China’s Foreign Minister Wang Yi has held talks with his Russian counterpart Sergei Lavrov following recent military strikes carried out by the United States and Israel on targets in Iran, as tensions in the Middle East continue to rise.
Measles cases across Europe and Central Asia fell sharply in 2025 compared to the previous year but health officials have warned that the risk of fresh outbreaks remains unless vaccination gaps are urgently addressed.
A Florida university has become a new hotspot in a widening U.S. measles outbreak, with health officials confirming multiple infections and hospitalisations.
The World Health Organization has added the Nipah virus to its list of the world’s top 10 priority diseases, alongside COVID-19 and the Zika virus, warning that its epidemic potential highlights the global risk posed by fast-spreading outbreaks.
Belgian authorities are examining suspected cases of infants falling ill after consuming recalled Nestle baby formula, amid warnings that confirmed infections may be underestimated due to limited testing requirements.
Two Nipah infections involving health workers in India have triggered heightened screening across Southeast Asia as authorities move to prevent the high fatality virus from spreading beyond the country.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment